Rheumatoid Arthritis-Critical Care

Introducing our high-performance Rheumatoid Arthritis-Critical Care, designed to provide incomparable relief to patients suffering from Rheumatoid Arthritis. Our product list includes Plamumab Adalimumab 40mg Inj, Exemptia 40 Mg, Rozel 60mg, 100 mg Remicade, and Rozel 60mg, all of which are elite medications that have been proven to be effective in treating Rheumatoid Arthritis. Our experience of over 1.0 years in the industry has allowed us to personalise our services to meet the unique needs of our clients. We offer the best price in the market, making it a deal that you cannot afford to miss. Our supply ability in the domestic market is All India, and we are exporters to Africa, Asia, Australia, Central America, Eastern Europe, Middle East, North America, South America, and Western Europe. Some of the advantages and features of our Rheumatoid Arthritis-Critical Care include its ability to reduce inflammation, relieve pain, improve joint function, prevent joint damage, and improve overall quality of life.

Mabura 40mg Injection

Price 8000.0 INR/ Piece

Get a Price/Quote

MOQ : 5 Pieces

Dosage Form
Injection

Drug Type
Injection

Function
Arthritis Aid

Indication
Rheumatoid Arthritis

Ingredients
Mabura 40mg Injection contains Adalimumab, a monoclonal antibody that blocks tumor necrosis factor-alpha (TNF- ), a key driver of inflammation in autoimmune diseases. It is used to treat conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn s disease, and ulcerative colitis by reducing inflammation, pain, swelling, and tissue damage, thereby improving quality of life. Mabura is administered as a subcutaneous injection, usually every two weeks, under medical supervision. Common side effects include injection site reactions, headache, fatigue, nausea, and mild infections, while serious risks may include severe infections, liver problems, blood disorders, or allergic reactions due to immune suppression. Regular monitoring and prompt reporting of symptoms like fever, persistent cough, or unusual bruising are essential during treatment.

Origin of Medicine
India

Packaging Type
1 prefilled syringe(s) of 0.8ml

Physical Form
Liquid

Quantity
1 Pieces

Recommended For
Rheumatoid Arthritis

Salt Composition
ADALIMUMAB

Suitable For
Adults

Know more

Adalipca 40mg Injection

MOQ : 5 Pieces

Dosage Form
Injection

Drug Type
Injection

Indication
Rheumatoid Arthritis

Ingredients
Adalipca 40mg Injection contains Adalimumab, a monoclonal antibody that blocks tumor necrosis factor-alpha (TNF- ), a key inflammatory protein involved in autoimmune diseases. It is used to treat rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn s disease, and ulcerative colitis by reducing inflammation, pain, swelling, and preventing further joint or tissue damage. Adalipca is given as a subcutaneous injection, usually once every two weeks, under medical supervision. Common side effects include injection-site reactions, headache, fatigue, nausea, and mild infections, while serious risks may include severe infections, liver problems, blood disorders, or allergic reactions due to immune suppression. Regular monitoring and prompt medical attention for symptoms like fever, persistent cough, unusual bruising, or yellowing of the skin are essential during treatment.

Origin of Medicine
India

Pacakaging (Quantity Per Box)
1 Prefilled Syringe(s) Of 0.8ml

Packaging Type
pfs

Physical Form
Liquid

Quantity
1 Pieces

Recommended For
Adults

Salt Composition
Adalimumab

Suitable For
Adults

Know more

Adfrar 40mg Injection

Price 800.0 INR/ Pack

Get a Price/Quote

MOQ : 5 Packs

Drug Type
Injection

Ingredients
Adfrar 40mg Injection contains Adalimumab, a monoclonal antibody that blocks tumor necrosis factor-alpha (TNF- ), a key mediator of inflammation in autoimmune diseases. It is used to treat conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn s disease, and ulcerative colitis by reducing inflammation, pain, swelling, and preventing further joint or tissue damage. Adfrar is administered as a subcutaneous injection, usually once every two weeks, under medical supervision. Common side effects include injection-site reactions, headache, fatigue, nausea, and mild infections, while serious risks may include severe infections, liver problems, blood disorders, or allergic reactions due to immune suppression. Regular monitoring and immediate medical attention for symptoms like fever, persistent cough, unusual bruising, or yellowing of the skin are essential during treatment.